Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ethamsylate (250mg) Tablet
Therapeutic Category
Cardiovascular, Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Alu Strip
Packaging
10*10
Price
₹81.75/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Etastyle 250 Tablet contains Ethamsylate (250mg), a hemostatic agent used to control and prevent excessive bleeding. Ethamsylate works by stabilizing capillary walls, improving blood clotting, and preventing blood vessel leakage. This action helps to reduce bleeding episodes caused by a variety of conditions. It is particularly effective in treating heavy menstrual bleeding (menorrhagia), nosebleeds (epistaxis), and preventing excessive bleeding during and after surgical procedures.
Ethamsylate is known for its ability to strengthen the walls of small blood vessels (capillaries), which makes it a useful treatment in conditions involving capillary fragility. The drug also promotes platelet aggregation, which is essential for proper clotting and helps reduce blood loss in individuals with conditions that involve abnormal bleeding or clotting.
Etastyle 250 Tablet is commonly used in gynecology to manage abnormal uterine bleeding, in surgical patients to reduce post-operative bleeding, and in patients with bleeding disorders. It can also be beneficial in preventing gastrointestinal bleeding in certain conditions.
Common side effects may include mild nausea, dizziness, headache, and skin rash. Rarely, allergic reactions or gastrointestinal discomfort may occur.
Etastyle 250 Tablet is indicated for the prevention and treatment of excessive bleeding in conditions such as menorrhagia, epistaxis, and post-surgical bleeding.
Consult a healthcare provider before use if pregnant, breastfeeding, or using anticoagulant medications.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ethamsylate 250mg Tablet is a hemostatic medicine used to control or reduce bleeding, making it a steady prescription and hospital-use product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in gynecological bleeding, surgical bleeding control, dental procedures, trauma cases, and post-operative hemorrhage management. It is commonly used in hospitals, clinics, and emergency care settings.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Ethamsylate 250mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital procurement, surgical and gynecological usage, and repeat institutional demand when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hemostatic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.